Relay Therapeutics Names Ben Wolf Chief Medical Officer

Relay Therapeutics has appointed Ben Wolf to serve as chief medical officer, the same position he held most recently at KSQ Therapeutics. His experience also includes positions at Blueprint Medicines (NASDAQ: [[ticker:BPMC]]), Merrimack Pharmaceuticals (NASDAQ: [[ticker:MACK]]), ImmunoGen, Amgen (NASDAQ: [[ticker:AMGN]]), and Genentech. Last year, Cambridge, MA-based Relay raised $400 million for its work developing cancer drugs based on an understanding of how the shape of a protein plays a role in disease.

Author: Frank Vinluan

Xconomy Editor Frank Vinluan is a business journalist with experience covering technology and life sciences. Based in Raleigh, he was a staff writer at the Triangle Business Journal covering technology, biotechnology and energy before joining MedCityNews.com as North Carolina bureau chief. Prior to moving to North Carolina’s Research Triangle in 2007 he held business reporting positions at The Des Moines Register and The Seattle Times.